Profile
Mehis Pold joined CeMines, Inc. in September 2004 as a Director of Development.
He received an MD from Tartu University in 1988.
He has nearly 15 years of experience in cancer research as a Postdoctoral and Junior Faculty Member at UCLA, West Los Angeles VA Hospital and the Burnham Institute.
He became a Junior Faculty Member at Division of Pulmonary and Critical Care Medicine in 2000.
Former positions of Mehis Pold
| Companies | Position | End |
|---|---|---|
CeMines, Inc.
 CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Corporate Officer/Principal | - |
Training of Mehis Pold
| University of Tartu | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
CeMines, Inc.
CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Health Technology |
- Stock Market
- Insiders
- Mehis Pold